Discover
STIM
Neuronetics, Inc.
1.35
2 x 0.97
2 x 1.66
bid
ask
+
0.05
3.85%
2 @ 04:00 PM
1.35 +0.00 (0.00%)
| Ytd | -2.17% | |
| 1y | -60.53% |
1.28
day range
1.38
0.80
52 week range
4.85
| Open | 1.30 | Prev Close | 1.30 | Low | 1.28 | High | 1.38 | Mkt Cap | 93.94M |
| Vol | 379.65K | Avg Vol | 2.19M | EPS | -0.54 | P/E | N/A | Forward P/E | -2.15 |
| Beta | 2.22 | Short Ratio | 4.05 | Inst. Own | 53.32% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-04 | 50-d Avg | 1.45 | 200-d Avg | 1.78 | 1yr Est | 2.67 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2024-11-12 | 2024-09 | -0.23 | -0.29 | -0.06 | -26.09% |
| 2024-08-12 | 2024-06 | -0.27 | -0.33 | -0.06 | -22.22% |
| 2024-08-12 | 2024-06 | -0.27 | N/A | N/A | N/A |
| 2024-05-07 | 2024-03 | -0.33 | -0.27 | 0.06 | 18.18% |
| 2024-05-07 | 2024-03 | -0.33 | N/A | N/A | N/A |
| 2024-03-05 | 2023-12 | -0.26 | N/A | N/A | N/A |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2024-08-14 | JMP Securities | Upgrade | Market Outperform | Market Outperform |
| 2024-08-13 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2024-08-12 | William Blair | Downgrade | Outperform | Market Perform |
| 2024-05-14 | William Blair | Upgrade | Market Perform | Outperform |
| 2024-03-06 | Piper Sandler | Upgrade | Overweight | Overweight |
| 2023-05-10 | JMP Securities | Upgrade | Market Outperform |
Profile
Neuronetics, Inc., a commercial stage medical technology company, designs, develops, and markets products for patients with neurohealth disorders in the United States and internationally. The company offers NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2023-05-24 | BAKEWELL JOHN K | Director | 114.35K | Stock Award(Grant) |
| 2023-05-24 | CAPPER JOSEPH H | Director | 43.15K | Stock Award(Grant) |
| 2024-09-11 | CASCELLA ROBERT A | Director | 453.10K | Purchase |
| 2024-05-29 | CONLEY SHERYL L | Director | 139.95K | Stock Award(Grant) |
| 2024-10-07 | FURLONG STEPHEN | Chief Financial Officer | 497.41K | Sale |
| 2023-05-24 | JAEGER WILFRED E | Director | 138.56K | Stock Award(Grant) |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-09-29 | Kent Lake PR LLC | 2.08M | 2.76M | 6.85% |
| 2024-09-29 | Cannell Capital LLC | 1.31M | 1.75M | 4.33% |
| 2024-09-29 | Vanguard Group Inc | 1.30M | 1.73M | 4.28% |
| 2024-09-29 | Masters Capital Management, LLC | 1.20M | 1.60M | 3.95% |
| 2024-09-29 | Balyasny Asset Management LLC | 1.14M | 1.52M | 3.77% |
| 2024-09-29 | Renaissance Technologies, LLC | 581.80K | 773.79K | 1.92% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2024-07-30 | First Eagle Small Opportunity Fund | 957.82K | 1.27M | 3.16% |
| 2024-09-29 | Vanguard Total Stock Market Index Fund | 849.50K | 1.13M | 2.80% |
| 2024-09-29 | Vanguard Extended Market Index Fund | 403.88K | 537.16K | 1.33% |
| 2024-10-30 | Fidelity Extended Market Index Fund | 162.07K | 215.55K | 0.53% |
| 2024-09-29 | EQ Advisors Trust-1290 VT Gamco Small Company Value Port | 75.00K | 99.75K | 0.25% |
| 2024-10-30 | iShares Micro Cap ETF | 62.05K | 82.52K | 0.20% |